The Past, Present and Future of Psychedelic Medicine
Rayyan Zafar
Up Next
BESA
Caroline Wright, Darcey Bussell, Matthew Koster-Marcon, Sean Gardner, Simon Winfield and Sven Huber
Psychedelic research plays a crucial role in mental health, with a focus on the historical use of LSD and MDMA. A shift in drug policy is necessary to support research and treatment. Clinical trials show psilocybin's promise in treating depression and addiction. The discussion also highlights the importance of educating youth about drugs and offers practical stress relief techniques, advocating for a compassionate approach to mental health care.Explore psychedelics' historical and recent research Recognise potential benefits for mental health Understand evolving roles in science
No Resources found for this Session
Rayyan Zafar
Dr. Rayyan Zafar is a neuropsychopharmacologist and postdoctoral researcher who recently completed his Ph.D. at Imperial College Centre for psychedelic research under the supervision of Prof David Nutt and Dr. David Erritzoe. His research investigates the neurobiology of substance use and behavioral addictions and how psychedelic therapy may be used to treat these. Rayyan also is a senior research officer at Drug Science, a research advisor for ITER investments, and advises for several psychedelic and cannabis biotechs and clinics.
BESA
Caroline Wright, Darcey Bussell, Matthew Koster-Marcon, Sean Gardner, Simon Winfield and Sven Huber
Supporting Children with Anxiety, Stress and Self-Harm
Tina Rae
Accelerating Learning in the Classroom
Douglas Fisher and Nancy Frey
Wellbeing through Animal Assisted Interventions
Helen Lewis and Russell Grigg